[1]
Zupanc, T. et al. 2024. Inclisiran, a Potent Lipid Lowering Treatment for Reaching LDL Goals on Top of Statins and Ezetimibe: A Single User Experiences. South East European Journal of Cardiology. 5, (Nov. 2024), 30–33. DOI:https://doi.org/10.3889/seejca.2024.6073.